Edition:
United States

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

512.00INR
3:51am EDT
Change (% chg)

Rs6.05 (+1.20%)
Prev Close
Rs505.95
Open
Rs506.00
Day's High
Rs515.00
Day's Low
Rs505.15
Volume
2,046,861
Avg. Vol
5,760,131
52-wk High
Rs784.25
52-wk Low
Rs432.70

Select another date:

Tue, Sep 19 2017

BRIEF-Sun Pharmaceutical Industries says unit gets U.S. FDA nod for new label for odomzo (sonidegib)

* Says one of co's units received approval from U.S. FDA for new label for odomzo (sonidegib) Source text - http://bit.ly/2f8WIsa Further company coverage:

BRIEF-Sun Pharmaceutical Industries seeks shareholders' nod for re-appointment of Dilip S. Shanghvi as MD

* Seeks shareholders' nod for re-appointment of dilip s. Shanghvi as managing director

UPDATE 2-India's Sun Pharma reports Q1 loss as generics business suffers

* Expects profit margin to improve in second-half of 2018 (Adds Managing Director comments from conference call)

BRIEF-Sun Pharma says co on track to achieve $300 mln synergies from Ranbaxy deal

* MD Dilip Shanghvi says on track to achieve $300 million synergies from Ranbaxy deal

BRIEF-Sun Pharmaceutical Industries posts June-qtr consol loss

* June quarter consol net loss 4.25 billion rupees versus profit 20.34 billion rupees last year

Indian shrs fall for 3rd day; US-N.Korea tensions spook investors

Aug 9 Indian shares fell for a third consecutive session on Wednesday, dragged down by financial and healthcare stocks, as escalating tensions on the Korean peninsula hit regional markets.

BRIEF-Sun Pharmaceutical Industries says unit to acquire 15.91 pct diluted stake of Krystal Biotech

* Unit agreed to acquire by way of allotment 203,135 series A preferred stock of Krystal Biotech Inc for $7 million Source text: (http://bit.ly/2vi3zH0) Further company coverage:

BRIEF-Sun Pharmaceutical Industries raises stake in Zenotech

* Raises stake in Zenotech from 46.85 percent of pre rights issue capital to 57.56 percent of post rights issue capital Source text - http://bit.ly/2u1jh7f Further company coverage:

BRIEF-Sun Pharma Advanced Research Co seeks members' nod to approve transactions with Sun Pharmaceutical Industries Inc

* Seeks members' nod to approve transactions with Sun Pharmaceutical Industries Inc, USA

BRIEF-Sun Pharmaceutical Industries announces manufacturing tie-up with Samsung Biologics

* Strategic manufacturing tie-up with Samsung Biologics for Tildrakizumab

Select another date: